AAPS Workshop Focuses on Development of Safer, More Acceptable Drug Delivery Devices

ARLINGTON, Va. — Industry leaders will discuss the development of drug delivery devices that will lead to safer and more palatable drug administration for both patients and health care practitioners, at an American Association of Pharmaceutical Scientists (AAPS) workshop on June 14, 2000, in San Francisco.

For many pharmaceutical and biotechnology-derived products, the delivery method or how a drug is introduced into the body has historically been through the use of ubiquitous vials and syringes or the use of pre-filled syringes. In recent years, new and unique delivery systems have been developed and marketed -- including pens, autoinjectors, mini-pumps, and needleless injectors.

"This workshop will feature industry leaders speaking on the following key topics, including: injection devices (pens, autoinjectors and mini-pumps), needleless injectors and alternate delivery by the pulmonary route," said Steven J. Shire, Ph.D., Genentech, Inc.

The AAPS Workshop on Development and Registration of Drug Delivery Devices Containing Biotechnology Products will be held at the Holiday Inn, San Francisco International Airport North in San Francisco, Calif.

Session topics include: "Insulin Pens: A Bridge to the Future," "Dry Powder Inhalation Technology," "Powder Injection for the Delivery of Therapeutic Proteins," and "Protein Delivery from Mechanical Devices -- Real World Problems."

For more information on this meeting, including a complete preliminary program, registration fees, and accommodations, visit AAPS Online at www.aaps.org/edumeet/biotech.

For presentation abstracts and speaker bios, contact Debbie Werfel at 703-248-4743 or werfel@aaps.org.

* * *